Alzheimer's Breakthrough Sunshine Act
Sponsored By: Representative Murphy, Patrick [D-FL-18]
Unknown
Summary
Alzheimer's Breakthrough Sunshine Act This bill amends the Internal Revenue Code to exclude from gross income for seven years amounts received from the sale of certain drugs for treating Alzheimer's disease and related dementias. The exclusion applies to the sale of a drug approved or licensed as a disease-modifying treatment for Alzheimer's disease and that has been designated as a breakthrough therapy under the Federal Food, Drug, and Cosmetic Act. The drug must be sold through an arm's length transaction by a holder of the approved application for the drug.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Murphy, Patrick [D-FL-18]
FL • D
Cosponsors
Rep. Fitzpatrick, Michael G. [R-PA-8]
PA • R
Sponsored 5/26/2016
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov